Q2 EPS Estimates for Henry Schein Lifted by Leerink Partnrs

Henry Schein, Inc. (NASDAQ:HSICFree Report) – Equities research analysts at Leerink Partnrs boosted their Q2 2025 earnings per share estimates for shares of Henry Schein in a report released on Monday, July 14th. Leerink Partnrs analyst M. Cherny now forecasts that the company will earn $1.22 per share for the quarter, up from their previous estimate of $1.16. The consensus estimate for Henry Schein’s current full-year earnings is $4.74 per share. Leerink Partnrs also issued estimates for Henry Schein’s Q4 2025 earnings at $1.22 EPS, FY2025 earnings at $4.83 EPS and FY2027 earnings at $5.72 EPS.

Henry Schein (NASDAQ:HSICGet Free Report) last posted its earnings results on Monday, May 5th. The company reported $1.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.11 by $0.04. Henry Schein had a net margin of 3.21% and a return on equity of 14.87%. The firm had revenue of $3.17 billion during the quarter, compared to analysts’ expectations of $3.24 billion. During the same period in the previous year, the business posted $1.10 EPS. The business’s revenue was down .1% compared to the same quarter last year.

Several other brokerages have also weighed in on HSIC. Evercore ISI lifted their price target on Henry Schein from $72.00 to $78.00 and gave the company an “in-line” rating in a research note on Wednesday, July 9th. Leerink Partners set a $75.00 price objective on Henry Schein in a research report on Monday. Wells Fargo & Company decreased their target price on Henry Schein from $80.00 to $75.00 and set an “equal weight” rating on the stock in a research report on Tuesday, May 6th. Wall Street Zen cut shares of Henry Schein from a “buy” rating to a “hold” rating in a research note on Thursday, April 17th. Finally, Robert W. Baird restated a “neutral” rating and set a $72.00 price objective (down from $82.00) on shares of Henry Schein in a research report on Monday. Eight equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $78.36.

Get Our Latest Stock Analysis on Henry Schein

Henry Schein Stock Down 1.9%

HSIC opened at $69.32 on Wednesday. The company has a fifty day moving average of $71.79 and a two-hundred day moving average of $71.32. The stock has a market capitalization of $8.44 billion, a price-to-earnings ratio of 21.66, a PEG ratio of 2.28 and a beta of 0.87. Henry Schein has a fifty-two week low of $60.56 and a fifty-two week high of $82.49. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.75 and a current ratio of 1.38.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in HSIC. Investment Management Corp VA ADV purchased a new stake in shares of Henry Schein during the fourth quarter worth $32,000. Rakuten Securities Inc. acquired a new position in Henry Schein during the first quarter worth about $34,000. Steph & Co. purchased a new stake in Henry Schein during the 2nd quarter valued at about $44,000. CX Institutional raised its holdings in Henry Schein by 107.3% in the 2nd quarter. CX Institutional now owns 651 shares of the company’s stock valued at $48,000 after acquiring an additional 337 shares during the last quarter. Finally, TD Private Client Wealth LLC lifted its stake in Henry Schein by 103.0% in the 2nd quarter. TD Private Client Wealth LLC now owns 668 shares of the company’s stock worth $49,000 after purchasing an additional 339 shares in the last quarter. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Henry Schein Company Profile

(Get Free Report)

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Featured Stories

Earnings History and Estimates for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.